<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
<PubmedBookArticle><BookDocument><PMID Version="1">28613655</PMID><ArticleIdList><ArticleId IdType="bookaccession">NBK430905</ArticleId></ArticleIdList><Book><Publisher><PublisherName>StatPearls Publishing</PublisherName><PublisherLocation>Treasure Island (FL)</PublisherLocation></Publisher><BookTitle book="statpearls">StatPearls</BookTitle><PubDate><Year>2022</Year><Month>01</Month></PubDate><BeginningDate><Year>2022</Year><Month>01</Month></BeginningDate><Medium>Internet</Medium></Book><ArticleTitle book="statpearls" part="article-30676">Tularemia</ArticleTitle><Language>eng</Language><AuthorList Type="authors" CompleteYN="Y"><Author ValidYN="Y"><LastName>Snowden</LastName><ForeName>Jessica</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>University of Nebraska Medical Center</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Simonsen</LastName><ForeName>Kari A.</ForeName><Initials>KA</Initials><AffiliationInfo><Affiliation>University of Nebraska Medical Center</Affiliation></AffiliationInfo></Author></AuthorList><PublicationType UI="D000072643">Study Guide</PublicationType><Abstract><AbstractText>Tularemia is an acute febrile zoonotic illness caused by the highly infectious Gram-negative organism <i>Francisella tularensis</i>. It is important to maintain a high degree of clinical suspicion for tularemia infections as symptoms can vary depending on the route of infection. F. Tularensis is one of the most infectious agents known; as few as 10-25 organisms can cause an infection in humans. Several subspecies of the bacteria are known and their virulence and geographical range also vary. In the US, tularemia is rare with most cases reported in the southern and central states. However, over the years cases have been reported in the Northern part of the country.</AbstractText><CopyrightInformation>Copyright © 2022, StatPearls Publishing LLC.</CopyrightInformation></Abstract><Sections><Section><SectionTitle book="statpearls" part="article-30676" sec="article-30676.s1">Continuing Education Activity</SectionTitle></Section><Section><SectionTitle book="statpearls" part="article-30676" sec="article-30676.s2">Introduction</SectionTitle></Section><Section><SectionTitle book="statpearls" part="article-30676" sec="article-30676.s3">Etiology</SectionTitle></Section><Section><SectionTitle book="statpearls" part="article-30676" sec="article-30676.s4">Epidemiology</SectionTitle></Section><Section><SectionTitle book="statpearls" part="article-30676" sec="article-30676.s5">Pathophysiology</SectionTitle></Section><Section><SectionTitle book="statpearls" part="article-30676" sec="article-30676.s6">Toxicokinetics</SectionTitle></Section><Section><SectionTitle book="statpearls" part="article-30676" sec="article-30676.s7">History and Physical</SectionTitle></Section><Section><SectionTitle book="statpearls" part="article-30676" sec="article-30676.s8">Evaluation</SectionTitle></Section><Section><SectionTitle book="statpearls" part="article-30676" sec="article-30676.s9">Treatment / Management</SectionTitle></Section><Section><SectionTitle book="statpearls" part="article-30676" sec="article-30676.s10">Differential Diagnosis</SectionTitle></Section><Section><SectionTitle book="statpearls" part="article-30676" sec="article-30676.s11">Prognosis</SectionTitle></Section><Section><SectionTitle book="statpearls" part="article-30676" sec="article-30676.s12">Complications</SectionTitle></Section><Section><SectionTitle book="statpearls" part="article-30676" sec="article-30676.s13">Enhancing Healthcare Team Outcomes</SectionTitle></Section><Section><SectionTitle book="statpearls" part="article-30676" sec="article-30676.s14">Review Questions</SectionTitle></Section><Section><SectionTitle book="statpearls" part="article-30676" sec="article-30676.s15">References</SectionTitle></Section></Sections><ContributionDate><Year>2022</Year><Month>5</Month><Day>6</Day></ContributionDate><ReferenceList><Reference><Citation>Frischknecht M, Meier A, Mani B, Joerg L, Kim OC, Boggian K, Strahm C. Tularemia: an experience of 13 cases including a rare myocarditis in a referral center in Eastern Switzerland (Central Europe) and a review of the literature. Infection. 2019 Oct;47(5):683-695.</Citation><ArticleIdList><ArticleId IdType="pubmed">30656604</ArticleId></ArticleIdList></Reference><Reference><Citation>Kopping EJ, Doyle CR, Sampath V, Thanassi DG. Contributions of TolC Orthologs to Francisella tularensis Schu S4 Multidrug Resistance, Modulation of Host Cell Responses, and Virulence. Infect Immun. 2019 Apr;87(4)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6434128</ArticleId><ArticleId IdType="pubmed">30670554</ArticleId></ArticleIdList></Reference><Reference><Citation>Kervyn A, Le Guern A, Gillard M, Bataille M, Modiano P. [Tularemia: A case report]. Ann Dermatol Venereol. 2019 Feb;146(2):131-134.</Citation><ArticleIdList><ArticleId IdType="pubmed">30638683</ArticleId></ArticleIdList></Reference><Reference><Citation>Balestra A, Bytyci H, Guillod C, Braghetti A, Elzi L. A case of ulceroglandular tularemia presenting with lymphadenopathy and an ulcer on a linear morphoea lesion surrounded by erysipelas. Int Med Case Rep J. 2018;11:313-318.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6237246</ArticleId><ArticleId IdType="pubmed">30519119</ArticleId></ArticleIdList></Reference><Reference><Citation>Donate-Pérez-Molino P, Castelló-Abietar C, Fernández-Suárez J, de Vicente JC. Tularemia: diagnosis of an unexpected oculoglandular case in a non-endemic area by universal PCR. Enferm Infecc Microbiol Clin (Engl Ed) 2019 Nov;37(9):620-621.</Citation><ArticleIdList><ArticleId IdType="pubmed">30595228</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwit NA, Schwartz A, Kugeler KJ, Mead PS, Nelson CA. Human tularaemia associated with exposure to domestic dogs-United States, 2006-2016. Zoonoses Public Health. 2019 Jun;66(4):417-421.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7122577</ArticleId><ArticleId IdType="pubmed">30556330</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Malley KJ, Bowling JD, Stinson E, Cole KS, Mann BJ, Namjoshi P, Hazlett KRO, Barry EM, Reed DS. Aerosol prime-boost vaccination provides strong protection in outbred rabbits against virulent type A Francisella tularensis. PLoS One. 2018;13(10):e0205928.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6197691</ArticleId><ArticleId IdType="pubmed">30346998</ArticleId></ArticleIdList></Reference><Reference><Citation>Waits A, Emelyanova A, Oksanen A, Abass K, Rautio A. Human infectious diseases and the changing climate in the Arctic. Environ Int. 2018 Dec;121(Pt 1):703-713.</Citation><ArticleIdList><ArticleId IdType="pubmed">30317100</ArticleId></ArticleIdList></Reference><Reference><Citation>Rojas-Moreno C, Bhartee H, Vasudevan A, Adiga R, Salzer W. Tetracyclines for Treatment of Tularemia: A Case Series. Open Forum Infect Dis. 2018 Sep;5(9):ofy176.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6122728</ArticleId><ArticleId IdType="pubmed">30191155</ArticleId></ArticleIdList></Reference></ReferenceList></BookDocument><PubmedBookData><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28613655</ArticleId></ArticleIdList></PubmedBookData></PubmedBookArticle></PubmedArticleSet>
